Sort   by:  
 Page size 
ProteomicsSerum Protein Biomarkers for Early Diagnosis of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Late presentation of disease at the time of diagnosis is one of the major reasons for dismal prognostic outcomes for PDAC patients. Currently, there is a lack of clinical biomarkers which can be used to diagnose PDAC patients a...
ORGANISM(S): Homo sapiens (Human) 
2024-03-05 | PXD046438 | Pride
Pancreatic cancer  serum  diagnostic biomarkers 
ProteomicsIdentification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant ChemotherapyIdentification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy
Neoadjuvant chemotherapy (NAC) has been of recent interest as an alternative to upfront surgery followed by adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma (PDAC). However, a subset of patients does not respond to NAC and may have been better managed by upfront surgery. Hence...
ORGANISM(S): Homo sapiens (Human) 
2020-04-16 | PXD017051 | Pride
Neoadjuvant chemotherapy Pancreatic ductal adenocarcinoma Swath-ms Proteomics Biomarkers 
Sort   by:  
 Page size